Protection Against Lethal Viral Infection by Vaccination with Nonimmunodominant Peptides

Journal of Immunology

Volumn 157, Issue 7, 1996, Pages 3039-3045

  Oukka, Mohamed ^a   Manuguerra, Jean Claude ^b   Livaditis, Nikos ^c   Tourdot, Sophie ^a   Riche, Nicole ^a   Vergnon, Isabelle ^a   Cordopatis, Pavlos ^c   Kosmatopoulos, Konstadinos ^a  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; EPITOPE; H2 ANTIGEN; INFLUENZA VACCINE; NP PROTEIN, INFLUENZA A VIRUS; NUCLEOPROTEIN; PEPTIDE FRAGMENT; RNA BINDING PROTEIN; VIRUS ANTIGEN;

AMINO ACID SEQUENCE; ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; CONSENSUS SEQUENCE; CROSS BREEDING; CYTOTOXIC T LYMPHOCYTE; IMMUNOLOGY; INFLUENZA VIRUS A; LUNG; LYMPHOCYTE DEPLETION; LYMPHOMA; MALE; MOLECULAR GENETICS; MOUSE; PATHOLOGY; T LYMPHOCYTE SUBPOPULATION; VACCINATION; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; CONSENSUS SEQUENCE; CROSSES, GENETIC; H-2 ANTIGENS; IMMUNODOMINANT EPITOPES; INFLUENZA A VIRUS; INFLUENZA VACCINES; LUNG; LYMPHOCYTE DEPLETION; LYMPHOMA; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; PEPTIDE FRAGMENTS; RNA-BINDING PROTEINS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VACCINATION; VIRAL CORE PROTEINS;

EID: 0030267527     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Lin, Y. L., and B. A. Askonas. 1981. Biological properties of an influenza virus specific killer T cell clone. J. Exp. Med. 154:225.
2. Taylor, P. M., and B. A. Askonas. 1986. Influenza nucleoprotein specific cytotoxic T cell clones are protective in vivo. Immunology 58:417.
3. Sethi, K. K., Y. Omata, and K. E. Schneiweis. 1983. Protection of mice from fatal herpes simplex virus type I infection by adoptive transfer of cloned virus specific and H-2 restricted cytotoxic T lymphocytes. J. Gen. Virol. 64:443.
4. Lukacher, A. E., V. L. Braciale, and T. J. Braciale. 1984. In vivo effector function of influenza virus specific cytotoxic T clones is highly specific. J. Exp. Med. 160:814.
5. Byrne, J. A., and M. B. A. Oldstone. 1984. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo. J. Virol. 51:682.
6. Townsend, A., F. M. Gotch, and J. Darey. 1985. Cytotoxic T cells recognize fragments of influenza nucleoprotein. Cell 42:457.
7. Falk, K., O. Rötzschke, S. Stevanovic, G. Jung, P. Walden, and H. G. Rammensee. 1991. Allele specific motifs revealed by sequencing of self peptides eluted from MHC molecules. Nature 351:290.
8. Rötzschke, O., and K. Falk. 1991. Naturally occurring peptide antigens derived from the MHC class I restricted processing pathway. Immunol. Today 12:447.
9. Rötzschke, O., K. Falk, S. Stevanovic, G. Jung, P. Walden, and H. G. Rammensee. 1991. Exact prediction of a natural T cell epitope. Eur. J. Immunol. 21:2891.
10. Lipford, G. B., M. Hoffman, H. Wagner, and K. Heeg. 1993. Primary in vivo response to ovalbumin. J. Immunol. 150:1212.
11. Pamer, E. G., J. T. Harty, and M. Bevan. 1991. Precise prediction of a dominant class I restricted epitope of Listeria monocytogenes. Nature 353:852.
12. d class I molecule. Eur. J. Immunol. 23:2005.
13. b cells. J. Immunol. 152:4843.
14. Aichele, P., H. Hergartner, R. M. Zinkernagel, and M. Schulz. 1990. Antiviral cytotoxic T cell response induced by in vitro priming with a free synthetic peptide. J. Exp. Med. 171:1815.
15. Schulz, M. R., M. Zinkernagel, and H. Hergartner. 1991. Peptide induced antiviral protection by cytoloxic T cells. Proc. Natl. Acad. Sci. USA 88:991.
16. + T cell help. J. Immunol. 147:4069.
17. Kast, M. W., L. Roux, J. Curren, H. J. J. Blom, A. C. Voordouw, R. H. Meloen, D. Kolakofsky, and C. M. Melief. 1991. Protection against lethal Sendai virus infection by in vivo priming of virus specific cytotoxic T lymphocytes with a free synthetic peptide. Proc. Natl. Acad. Sci. USA 88:2283.
18. Zhou, X., U. M. Abdel Motal, L. Berg, and M. Jondal. 1992. In vivo priming of cytotoxic T lymphocyte response in relation to in vitro up-regulation of major histocompatibility complex class I molecules by short synthetic peptides. Eur. J. Immunol. 22:3085.
19. Blum-Tirouvanzian, U., C. Benghadi-Rais, M. A. Roggero, D. Valmori, S. Bertholet, N. Fasel, and G. Corradin. 1994. Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides. J. Immunol. 153:4134.
20. Falk, K., O. Rötzschke, K. Deres, J. Metzger, G. Jung, and H. G. Rammensee. 1991. Identification of naturally processed viral nonapeptides allows their quantification in infected cells and suggests an allele specific T cell epitope forecast. J. Exp. Med. 174:425.
21. Oldstone, M. B. A., A. Tishon, R. Geckeler, H. Lewicki, and J. L. Whitton. 1992. A common antiviral cytotoxic T lymphocyte epitope for diverse major histocompatibility complex haplotypes: implications for vaccination. Proc. Natl. Acad. Sci. USA 89:2752.
22. Kast, M. W., R. M. P. Brandt, and C. J. M. Melief. 1993. Strict peptide length is not required for the induction of cytotoxic T lymphocyte mediated anti-viral protection by peptide vaccination. Eur. J. Immunol. 23:1189.
23. Isobe, H., T. Moran, S. Li, A. Young, S. Nathenson, P. Palese, and C. Bona. 1995. Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant. J. Exp. Med. 181:203.
24. Kast, W. M., A. M. Bronhorst, L. P. De Waal, and C. J. M. Melief. 1986. Cooperation between cytotoxic and helper T lymphocytes in protection against lethal virus infection: protection by T cells is MHC-restricted and MHC-regulated; a model for MHC-disease associations. J. Exp. Med. 164:723.
25. Barber, L. D., and P. Parham. 1994. The essence of epitopes. J. Exp. Med. 180: 1191.
26. b restricted ovalbumin peptide and an assessment of the predictive power of MHC-binding motifs. Eur. J. Immunol 22:2663.
27. Chen, W., S. Khilko, J. Fecondo, D. H. Margoulis, and J. McCluskey. 1994. Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by non-dominant anchor residues. J. Exp. Med. 180:1471.
28. Shepherd, J. C., T. N. M. Schumacher, P. G. Ashton-Rickardt, S. Imaeda, H. L. Ploegh, C. A. Janeway, Jr., and S. Tonegawa. 1993. TAPI-dependent peptide translocation in vitro is ATP dependent and peptide selective. Cell 74:577.
29. Neisig, A., J. Roesle, A. J. A. M. Sijts, F. Ossendrop, M. C. W. Feltcamp, W. M. Kast, C. J. M. Melief, and J. J. Neefjes. 1995. Major differences in transporter associated with antigen presentation (TAP) dependent translocation of MHC class I presentable peptides and the effects of flanking sequences. J. Immunol. 154:1273.
30. Niedermann, G., S. Butz, H. G. Inhelfeld, R. Grimm, M. Lucchiari, H. Hoschützsky, G. Jung, B. Maier, and K. Eichmann. 1995. Contribution of proteasome mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 2:289.
31. Obst, R., E. A. Armandola, M. Nijenhuis, F. Momberg, and G. J. Hämmerling. 1995. TAP polymorphism does not influence transport of peptide variants in mice and humans. Eur. J. Immunol. 25:2170.
32. g7 (NOD/Lt) haplotype translocate similar sets of peptides. Proc. Natl. Acad. Sci. USA 91: 13004.
33. Powis, S. J., E. V. Deverson, W. J. Coadwell, A. Ciruela, N. S. Huskisson, H. Smith, G. W. Butcher, and J. C. Howard. 1992. Effects of polymorphism of an MHC-linked transporter on the peptides assembled in class I molecule. Nature 357:211.
34. Sette, A., A. Vitiello, B. Reherman, P. Fowler, R. Nayersina, W. M. Kast, C. J. M. Melief, C. Oseroff, L. Yuan, J. Ruppert, J. Sidney, M.-F. del Guercio, S. Southwood, R. T. Kubo, R. W. Chesnut, H. M. Grey, and F. V. Chisari. 1994. The relationship between class I binding affinity and immunogenicity of cytotoxic T cell epitopes. J. Immunol. 153:5586.
35. Van der Burg, S. H., M. J. W. Visseren, R. M. P. Brandt, W. M. Kast, and C. J. M. Melief. 1996. Immunogenicity of peptides bound to MHC class I molecules depends on the MHC peptide complex stability. J. Immunol. 156:3308.
36. Ohno, S. 1992. Self to cytotoxic T cells has to be 1000 or less high affinity nonapeptides for MHC antigen. Immunogenetics 36:22.
37. Coullin, I., B. Culmann-Penciolli, E. Gomard, J. P. Levy, J. G. Guillet, and S. Saragosti. 1994. Impaired CTL recognition due to genetic variations in the main immunogenic region of the HIV-I nef protein. J. Exp. Med. 180:1129.
38. Philips, R. E., S. Rowland-Jones, D. F. Nixon, F. M. Gotch, J. P. Edwards, A. O. Ogunlesi, J. G. Elvin, J. A. Rothbard, C. R. M. Bangham, C. R. Rizza, and A. J. McMichael. 1991. Human immunodeficiency virus genetic variations that can escape cytotoxic T cell recognition. Nature 354:453.
39. + population. Science 260:98.
40. Bertoletti, A., A. Costanzo, F. V. Chisari, M. Levrero, M. Artini, A. Sette, A. Penna, T. Giuberti, F. Fiaccadori, and C. Ferrari. 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 180:933.
41. Koup, R. A. 1994. Virus escape from CTL recognition. J. Exp. Med. 180:779.
42. Wölfel, T., A. Van Pel, V. Brichard, J. Schneider, B. Seliger, K. H. M. zum Büschenfelde, and T. Boon. 1994. Two tyrosinase nonapeptides recognized on HLA-A2 melanomas by autologous cytolytic T lymphocytes. Eur. J. Immunol. 24:759.
43. Brichard, V., A. Van Pel, T. Wölfel, C. Wölfel, E. De Plaen, B. Lethe, P. Coulie, and T. Boom. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489.
44. Mougdil, K. D., and E. E. Sercarz. 1994. Can antitumor immune responses discriminate between self and nonself? Immunol. Today 15:353.
45. Cibotti, R., J. M. Kanellopoulos, J. P. Cabaniols, O. Halle Pannenko, K. Kosmatopoulos, E. Sercarz, and P. Kourilsky. 1992. Tolerance to a self protein involves its immunodominant but not subdominant determinants. Proc. Natl. Acad. Sci. USA 89:416.
46. Cabaniols, J. P., R. Cibotti, P. Kourilsky, K. Kosmatopoulos, and J. M. Kanellopoulos. 1994. Dose-dependent T cell tolerance to an immunodominant self peptide. Eur. J. Immunol. 24:1743.